{
    "nctId": "NCT04918589",
    "briefTitle": "Tranexamic Acid for Alloplastic Breast Reconstruction",
    "officialTitle": "Effects of Tranexamic Acid for Alloplastic Breast Reconstruction: A Randomized Control Trial",
    "overallStatus": "UNKNOWN",
    "conditions": "Hematoma Postoperative, Breast Cancer, Tranexamic Acid",
    "studyType": "INTERVENTIONAL",
    "phase": "PHASE3",
    "allocation": "RANDOMIZED",
    "primaryPurpose": "TREATMENT",
    "enrollmentCount": 106,
    "primaryOutcomeMeasure": "Hematoma",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Are 18 years or older;\n* Are undergoing one- or two-stage bilateral alloplastic breast reconstruction immediately after bilateral mastectomy at either Hamilton Health Sciences or St. Joseph's Hospital Hamilton.\n\nExclusion Criteria:\n\n* Taking therapeutic anticoagulation;\n* Taking antiplatelet drugs;\n* Pregnant or breast feeding;\n* Allergic to TXA;\n* Cannot provide informed consent;\n* Alloplastic reconstruction is not performed immediately after mastectomy;\n* Have a documented coagulopathy or bleeding disorder, acquired disturbances of colour vision, subarachnoid hemorrhage, hematuria, irregular menstrual bleeding, or seizure disorder.",
    "sex": "FEMALE",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}